The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty‐year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis
Abstract
Objective: To identify in patients with Raynaud's phenomenon (RP) independent markers that predict progression to definite systemic sclerosis (SSc) and to determine in patients with progression to SSc the type and sequence of microvascular damage and its relationship to SSc‐specific autoantibodies. Methods: Consecutive patients referred for evaluation of RP who had no definite connective tissue disease were evaluated for microvascular damage by nailfold capillary microscopy (NCM) and for anticentromere (anti–CENP‐B), anti‐Th/To, anti–topoisomerase I, and anti–RNA polymerase III (anti–RNAP III) autoantibodies by specific assays. Patients were studied prospectively. Results: Of the 586 patients who were followed up for 3,197 person‐years, 74 (12.6%) developed definite SSc. A characteristic sequence of microvascular damage was identified, starting with enlarged capillaries, followed by capillary loss, and then by capillary telangiectases. Definite SSc was diagnosed in close temporal relationship to capillary loss. Enlarged capillaries, capillary loss, and SSc‐specific autoantibodies independently predicted definite SSc. Anti–CENP‐B and anti‐Th/To antibodies predicted enlarged capillaries; these autoantibodies and anti–RNAP III predicted capillary loss. Each autoantibody was associated with a distinct time course of microvascular damage. At followup, 79.5% of patients with 1 of these autoantibodies and abnormal findings on NCM at baseline had developed definite SSc. Patients with both baseline predictors were 60 times more likely to develop definite SSc. The data validated the proposed criteria for early SSc. Conclusion: In RP evolving to definite SSc, microvascular damage is dynamic and sequential, while SSc‐specific autoantibodies are associated with the course and type of capillary abnormalities. Abnormal findings on NCM at baseline together with an SSc‐specific autoantibody indicate a very high probability of developing definite SSc, whereas their absence rules out this outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
Criteria for the classification of early systemic sclerosis.
LeRoy, E. C., & Medsger, T. A. (2001) · PubMed · Cited by 1,384
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
Clements, P. J., Lachenbruch, P. A., Siebold, J., White, B., Weiner, S. J., Martin, R. W., Weinstein, A., Weisman, M. H., Mayes, M. D., & Collier, D. H. (1995) · PubMed · Cited by 874
Korn, J. H., Mayes, M., Matucci Cerinic, M., Rainisio, M., Pope, J., Hachulla, E., Rich, E., Carpentier, P., Molitor, J., Seibold, J. R., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20676 · Cited by 728
Wigley, F. M., & Flavahan, N. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507638 · Cited by 420
Wigley, F. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013013 · Cited by 394
Distler, J. H. W., Jüngel, A., Huber, L. C., Schulze‐Horsel, U., Zwerina, J., Gay, R. E., Michel, B. A., Hauser, T., Schett, G., Gay, S., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22314 · Cited by 383
The CREST syndrome: A distinct serologic entity with anticentromere antibodies
Fritzler, M. J., Kinsella, T. D., & Garbutt, E. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90462-3 · Cited by 366
Self-citationSCUSSEL-LONZETTI, L., JOYAL, F., RAYNAULD, J.-P., ROUSSIN, A., RICH, É., GOULET, J.-R., RAYMOND, Y., & SENÉCAL, J.-L. (2002) · Medicine · doi:10.1097/00005792-200203000-00005 · Cited by 361
Self-citationFollowing the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
Jimenez, S. A., & Derk, C. T. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00010 · Cited by 316
Lonzetti, L. S., Joyal, F., Raynauld, J., Roussin, A., Goulet, J., Rich, �., Choquette, D., Raymond, Y., & Sen�cal, J.-L. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3<735::aid-anr125>3.0.co;2-f · Cited by 222
Self-citationSpencer-Green, G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.6.595 · Cited by 222
Koenig, M., Fritzler, M. J., Targoff, I. N., Troyanov, Y., & Senécal, J.-L. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2276 · Cited by 199
Self-citationGiordano, M., Valentini, G., Migliaresi, S., et al. (1986) · PubMed · Cited by 196
A prospective study of raynaud phenomenon and early connective tissue disease
Harper, F. E., Maricq, H. R., Turner, R., et al. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90846-4 · Cited by 162
Evolution of primary raynaud's phenomenon (raynaud's disease) to connective tissue disease
Gerbracht, D. D., Steen, V. D., Ziegler, G. C., Medsger, T. A., & Rodnan, G. P. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280114 · Cited by 101
Kuwana, M., Okano, Y., Pandey, J. P., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21232 · Cited by 96
Advances and applications of multiplexed diagnostic technologies in autoimmune diseases
Fritzler, M. (2006) · Lupus · doi:10.1191/0961203306lu2327oa · Cited by 78
Self-citationWollersheim, H. C. H., Thien, T., Hoet, M. H., et al. (1989) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1989.tb00271.x · Cited by 55
Serological arguments for classifying Raynaud's phenomenon as idiopathic.
Gentric, A., Blaschek, M., Jf, L. N., Johanet, C., Jouquan, J., Lamour, A., Abuaf, N., PENNEC, Y. L., & Youinou, P. (1990) · PubMed · Cited by 20
Gravellese (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200002)43:2 · Cited by 2
Cited by
van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., Matucci‐Cerinic, M., Naden, R. P., Medsger, T. A., Carreira, P. E., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38098 · Cited by 3,409
van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., Matucci-Cerinic, M., Naden, R. P., Medsger, T. A., Carreira, P. E., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204424 · Cited by 2,886
Allanore, Y., Simms, R., Distler, O., Trojanowska, M., Pope, J., Denton, C. P., & Varga, J. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.2 · Cited by 876
Volkmann, E. R., Andréasson, K., & Smith, V. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01692-0 · Cited by 616
Review: Evidence That Systemic Sclerosis Is a Vascular Disease
Matucci‐Cerinic, M., Kahaleh, B., & Wigley, F. M. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37988 · Cited by 452
Metadata
- Authors
- Koenig, M., Joyal, F., Fritzler, M. J., Roussin, A., Abrahamowicz, M., Boire, G., Goulet, J., Rich, É., Grodzicky, T., Raymond, Y., & Senécal, J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2008-11-26
- Volume
- 58
- Issue
- 12
- Pages
- 3902-3912
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2089255535
- Cited by
- 615
- References
- 22
- FWCI
- 14.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.